Interventional × Thalidomide × Other hematologic neoplasm × Clear all Thalidomide for the Symptomatic Large Granular Lymphocytic Leukemia
Phase 2 Recruiting
48 enrolled
The Maintenance Treatment of "ITIVA" in AML Patients
Phase NA Recruiting
130 enrolled
ThRiL
Phase 2 Completed
15 enrolled 12 charts
Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder
Phase 2 Completed
15 enrolled
TPM Regimen (Thalidomide, Prednisone and Methotrexate) in LGLL
Phase 2/3 Unknown
42 enrolled
BDHCLL001
Phase 2 Recruiting
50 enrolled
Blood and Marrow Transplant Clinical Research Network
Phase NA Completed
Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer
Phase 2 Completed
101 enrolled 10 charts
Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD)
Phase 3 Terminated
90 enrolled 10 charts
Fludarabine and Thalidomide in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia
Phase 1/2 Completed
43 enrolled 8 charts
Thalidomide in Treating Patients With Relapsed Chronic Lymphocytic Leukemia
Phase 2 Completed
41 enrolled
Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Phase 1 Completed
Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome
Phase 2 Completed
Thalidomide With or Without Fludarabine in Treating Patients With Hematologic Cancer
Phase 2 Terminated
70 enrolled
Thalidomide in Treating Anemia in Patients With Myelodysplastic Syndrome
Phase 2 Completed
Thalidomide in Treating Patients With Myelodysplastic Syndrome
Phase 2 Completed
29 enrolled
Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Phase 2 Completed
45 enrolled
Thalidomide Anti-Angiogenesis Therapy of Relapsed or Refractory Leukemia
Phase 2 Completed
25 enrolled
Thalidomide and Docetaxel in Treating Patients With Advanced Cancer
Phase 1 Completed
26 enrolled
Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDS
Phase 2 Completed
42 enrolled